Furthermore, targeting STAT activity that is strictly regulated by SOCS1 and SOCS3 proteins, by inhibiting tyrosine kinases, could allow avoiding the subversion of the innate immune responses during a bacterial infection and therefore represents an attractive antibacterial therapeutic approach. The gene discussed is SOCS1; the disease is bacterial infectious disease.